No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
559 |
4. Check minimum number of eventsNone |
559 |
5. Include endpointsNone |
559 |
6. Filter based on genotype QC (FinnGen only) |
482 |
Control definitions (FinnGen only)
- Control exclude
- AB1_SEXUAL_TRANSMISSION
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF13
Similar endpoints
↥List of similar endpoints to
Early syphilis, including avohilmo
based on the number of shared cases.
Similar with more cases:
- Infections with a predominantly sexual mode of transmission, including avohilmo
- Certain infectious and parasitic diseases, including avohilmo
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 482 | 156 | 326 |
| Unadjusted period prevalence (%) | 0.12 | 0.06 | 0.15 |
| Median age at first event (years) | 38.18 | 30.03 | 42.08 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 527
- Matched controls
- 5270
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
22.9
269.8
239
184
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
134.9
230.2
116
11
A51.3
ICD-10 Finland
Secondary syphilis of skin and mucous membranes
+∞
224.5
199
*
A51.0
ICD-10 Finland
Primary genital syphilis
+∞
209.8
187
*
WW200
NOMESCO Finland
Immunization
27.4
157.3
113
52
A56.0
ICD-10 Finland
Chlamydial infection of lower genitourinary tract
45.0
153.5
93
25
A63.0
ICD-10 Finland
Anogenital (venereal) warts
38.7
147.3
93
29
A56.3
ICD-10 Finland
Chlamydial infection of anus and rectum
1432.5
120.8
113
*
A54.6
ICD-10 Finland
Gonococcal infection of anus and rectum
+∞
101.4
94
*
A51.9
ICD-10 Finland
Early syphilis, unspecified
+∞
89.1
83
*
Y25
ICPC
Fear sexually transm disease male
10.2
89.0
112
136
A54.5
ICD-10 Finland
Gonococcal pharyngitis
966.5
86.1
82
*
A54.0
ICD-10 Finland
Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
+∞
70.4
66
*
Z29.2
ICD-10 Finland
Other prophylactic chemotherapy
132.6
56.1
59
5
Z21
ICD-10 Finland
Asymptomatic human immunodeficiency virus [HIV] infection status
200.1
53.0
54
*
A53.9
ICD-10 Finland
Syphilis, unspecified
+∞
51.9
49
*
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
76.5
49.1
55
8
D06BB04
ATC
podophyllotoxin; topical
6.8
48.7
83
140
A60.0
ICD-10 Finland
Herpesviral infection of genitalia and urogenital tract
16.3
43.8
38
25
09100
ICD-8 Finland
Early syphilis, symptomatic, Primary syphilis, except extragenital chancre
+∞
43.3
41
*
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
4.5
32.0
89
230
A51.5
ICD-10 Finland
Early syphilis, latent
+∞
26.3
25
*
Z20.2
ICD-10 Finland
Contact with and exposure to infections with a predominantly sexual mode of transmission
6.6
25.3
42
68
Y70
ICPC
Syphilis male
+∞
25.2
24
*
A56.4
ICD-10 Finland
Chlamydial infection of pharynx
136.5
24.8
26
*
Z3231
NOMESCO Finland
Registered nurse
2.7
24.4
177
822
0913A
ICD-9 Finland
Early syphilis, symptomatic, Secondary syphilis of skin or mucous membranes
+∞
24.1
23
*
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
4.9
23.2
54
120
Y71
ICPC
Gonorrhoea male
+∞
23.1
22
*
Z2221
NOMESCO Finland
Medical doctor
2.7
22.9
168
781
09120
ICD-8 Finland
Early syphilis, symptomatic, Secondary syphilis of skin and mucous membranes
+∞
21.0
20
*
ULA02
NOMESCO Finland
Kolposcopy
4.4
20.9
55
135
Z25.1
ICD-10 Finland
Need for immunization against influenza
4.6
19.9
49
114
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
109.2
19.7
21
*
A51.4
ICD-10 Finland
Other secondary syphilis
+∞
17.8
17
*
B23.0
ICD-10 Finland
Acute HIV infection syndrome
+∞
16.8
16
*
J05AB11
ATC
valaciclovir; oral
2.7
15.7
101
432
A55
ICD-10 Finland
Chlamydial lymphogranuloma (venereum)
+∞
15.7
15
*
J01MA02
ATC
ciprofloxacin; systemic
2.1
15.4
211
1252
ZX114
NOMESCO Finland
Intramuscular
11.8
15.4
28
25
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
6.9
15.4
24
36
EB1AA, ,
SPAT
3.6
15.4
53
158
D06BB10
ATC
imiquimod; topical
4.3
15.0
40
99
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
4.5
14.5
36
84
D11
ICPC
Diarrhoea
2.6
14.1
94
408
Y99
ICPC
Genital disease male other
20.7
13.9
20
10
J05AB01
ATC
aciclovir; systemic
2.3
13.1
122
615
TAB00
NOMESCO Finland
Lumbar puncture
3.7
13.1
42
119
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.1
12.5
167
969
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
12.0
12.4
22
19
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
12.2
127
668
WX110, ,
SPAT
3.3
11.7
45
144
A52.9
ICD-10 Finland
Late syphilis, unspecified
+∞
11.5
11
*
A52.1
ICD-10 Finland
Symptomatic neurosyphilis
+∞
11.5
11
*
WNF00
NOMESCO Finland
Infection source and contact determination
35.9
11.3
14
*
Z71.8
ICD-10 Finland
Other specified counselling
1.9
11.3
199
1263
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.0
10.8
163
978
WX290, ,
SPAT
4.0
10.8
31
81
J01AA02
ATC
doxycycline; systemic
2.0
10.8
390
3102
EB1SA, ,
SPAT
3.3
10.5
41
132
A54.9
ICD-10 Finland
Gonococcal infection, unspecified
+∞
10.4
10
*
J01DB01
ATC
cefalexin; oral
2.2
9.7
445
3763
J01FA10
ATC
azithromycin; systemic
1.8
9.6
316
2396
A97
ICPC
No disease
2.0
9.5
115
637
A56.2
ICD-10 Finland
Chlamydial infection of genitourinary tract, unspecified
30.6
9.4
12
*
Z20.6
ICD-10 Finland
Contact with and exposure to human immunodeficiency virus [HIV]
22.2
9.4
13
6
I84
ICD-10 Finland
Hemorrhoids
4.7
9.1
21
46
D06AX01
ATC
fusidic acid; topical
2.4
9.0
64
285
N48.1
ICD-10 Finland
Balanoposthitis
3.4
8.9
33
103
LEB00
NOMESCO Finland
Biopsy of vagina
8.7
8.4
17
20
A53.0
ICD-10 Finland
Latent syphilis, unspecified as early or late
+∞
8.4
8
*
0910A
ICD-9 Finland
Early syphilis, symptomatic, Genital syphilis (primary)
+∞
8.4
8
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.9
8.3
114
656
U07
ICPC
Urine symptom/complaint other
2.8
8.3
43
164
N05BA04
ATC
oxazepam; oral
1.9
8.2
132
800
N06AX11
ATC
mirtazapine; oral
1.7
8.1
183
1229
P01AB01
ATC
metronidazole; oral, rectal
1.7
7.9
187
1270
S29
ICPC
Skin symptom/complaint other
1.9
7.7
103
586
F43.29
ICD-10 Finland
Adaptation disorder UNS
3.9
7.6
22
58
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.5
7.4
49
211
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.8
7.4
125
768
A03.1
ICD-10 Finland
Shigellosis due to Shigella flexneri
+∞
7.3
7
*
A51.1
ICD-10 Finland
Primary anal syphilis
+∞
7.3
7
*
A03.3
ICD-10 Finland
Shigellosis due to Shigella sonnei
+∞
7.3
7
*
B17.1
ICD-10 Finland
Acute hepatitis C
20.3
7.2
10
5
R74
ICPC
Upper respiratory infection acute
1.7
7.0
196
1384
Z01.7
ICD-10 Finland
Laboratory examination
1.9
6.7
94
542
R4120
NOMESCO Finland
Occupational therapy
2.6
6.6
37
147
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.0
6.6
71
375
D01BA02
ATC
terbinafine; oral
1.7
6.4
136
889
N48.8
ICD-10 Finland
Other specified disorders of penis
8.3
6.4
13
16
N05CF01
ATC
zopiclone; oral
1.7
6.3
144
958
A52.3
ICD-10 Finland
Neurosyphilis, unspecified
+∞
6.3
6
*
A51.2
ICD-10 Finland
Primary syphilis of other sites
+∞
6.3
6
*
A52.8
ICD-10 Finland
Late syphilis, latent
+∞
6.3
6
*
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.3
6.2
46
209
EMB10
NOMESCO Finland
Tonsillectomy
2.4
6.1
40
171
B18.2
ICD-10 Finland
Chronic viral hepatitis C
4.2
6.1
16
39
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.8
6.1
31
117
B37.4
ICD-10 Finland
Candidiasis of other urogenital sites
12.7
6.1
10
8
D19
ICPC
Teeth/gum symptom/complaint
1.6
6.1
170
1191
F52.2
ICD-10 Finland
Failure of genital response
3.1
6.0
25
84
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
128
29
57.98
222.13
17.5
8.9
1474.22
102.00
u/ml
—
74
9
241
304
13.77
195.61
12.7
1.8
—
—
—
0
0
177
147
17.62
187.29
6.4
3.9
142.48
331.35
mg/l
1.32
154
71
247
364
11.89
176.83
12.9
1.9
—
—
—
0
0
106
32
41.21
170.07
2.9
3.2
29.53
43.64
%
2.92
16
18
148
6
341.77
153.20
4.3
1.7
—
—
—
0
0
269
749
6.29
98.35
9.7
2.0
—
—
—
0
0
278
813
6.12
95.75
10.6
2.1
—
—
—
0
0
154
427
4.68
52.23
2.2
3.0
31.90
42.31
u/l
0.48
146
364
46
48
10.40
40.03
1.1
1.1
—
—
—
0
0
40
61
7.01
25.46
1.1
1.1
—
—
—
0
0
73
204
3.99
23.41
1.3
1.4
222.19
227.69
miu/ml
0.04
27
113
156
700
2.75
22.83
2.3
2.9
0.79
0.81
e6/l
0.05
61
366
372
2536
2.59
21.90
13.5
9.8
3.76
4.14
e9/l
2.84
332
2226
342
2272
2.44
20.83
7.4
6.8
13.04
12.01
umol/l
0.43
330
2171
143
655
2.62
19.76
2.3
3.0
2.81
1.37
e6/l
0.53
48
318
208
1158
2.32
18.53
2.8
3.1
0.22
0.33
e6/l
0.80
129
843
279
1761
2.24
18.26
5.2
5.4
37.84
36.69
g/l
2.65
263
1681
65
203
3.51
17.60
1.6
1.4
—
—
—
0
0
29
49
6.20
16.68
2.3
1.7
—
—
—
0
0
224
1337
2.17
16.36
3.0
3.2
16.54
101.90
e6/l
1.08
146
1022
296
2009
2.08
14.99
15.4
10.7
0.00
0.00
e9/l
0.46
251
1650
326
2306
2.08
14.60
4.0
3.3
0.00
0.00
estimate
-0.00
42
490
329
2336
2.09
14.57
4.1
3.4
0.00
0.02
estimate
1.06
38
442
328
2333
2.07
14.37
4.0
3.3
0.00
3.31
estimate
0.50
42
491
51
157
3.49
14.07
2.7
1.5
—
—
—
0
0
416
3276
2.28
13.49
9.6
8.3
76.20
77.53
u/l
0.30
408
3142
251
1667
1.97
12.84
10.4
3.3
36.55
34.95
u/l
0.10
241
1586
334
2607
1.77
8.82
4.2
3.9
382.00
137.18
e6/l
—
5
39
483
4288
2.51
8.28
18.0
12.9
90.88
88.80
ml/min/173m2
1.46
442
3956
54
234
2.46
8.03
1.8
1.3
—
—
—
0
0
324
2548
1.71
7.93
6.1
5.5
6.39
6.70
mmol/l
2.18
318
2409
495
4474
2.75
7.63
15.4
14.0
24.51
23.45
mg/l
0.32
428
3622
255
1913
1.65
7.23
2.2
1.9
1.41
1.49
mmol/l
0.87
241
1680
27
94
2.97
6.14
2.4
3.4
2.00
2.77
index
—
8
59
30
111
2.81
6.12
1.4
1.1
—
—
—
0
0
30
112
2.78
6.03
1.4
1.1
—
—
—
0
0
63
331
2.03
5.89
3.0
2.7
75.82
73.95
ml/min/173m2
0.16
33
147
38
162
2.45
5.88
2.3
3.1
1.12
1.32
mg/l
2.20
32
151
16
33
4.97
5.47
3.3
2.7
—
—
—
0
0
145
1014
1.59
5.11
2.2
2.4
—
—
—
0
0
200
1507
1.53
5.05
3.2
3.6
8.81
8.76
mmol/l
0.04
177
1317
49
250
2.06
4.97
3.0
3.5
23.77
24.37
mmol/l
0.55
49
250
56
300
1.97
4.97
2.0
1.8
0.26
0.35
mg/l
0.72
32
153
371
3191
1.55
4.93
4.5
4.0
10.21
9.78
mm/h
0.27
363
3015
8
8
10.13
4.53
1.1
1.1
—
—
—
0
0
112
760
1.60
4.42
2.5
2.5
15.26
14.34
nmol/l
0.57
106
717
130
914
1.56
4.41
2.6
2.5
4.39
5.69
e6/l
0.56
118
837
59
343
1.81
4.10
2.0
2.0
40.41
36.61
nmol/l
0.52
59
333
16
55
2.97
3.76
1.3
2.0
—
—
—
0
0
142
1054
1.48
3.67
1.7
1.6
19.84
19.64
nmol/l
0.06
127
914
25
111
2.31
3.60
1.8
1.4
23.65
21.96
e6/l
0.04
17
81
458
4230
1.63
3.56
6.0
4.5
5.91
5.92
mmol/l
0.01
437
3977
503
4781
2.14
3.43
23.8
17.1
78.12
79.27
umol/l
0.56
503
4743
25
114
2.25
3.40
1.8
1.4
474.65
855.40
e6/l
0.21
17
85
136
1015
1.46
3.39
2.0
1.6
—
—
—
0
0
8
15
5.40
3.20
4.8
2.1
—
—
—
0
0
214
1746
1.38
3.19
6.2
7.3
1.20
1.21
mmol/l
0.64
200
1645
38
214
1.84
2.97
1.5
1.6
7.84
6.18
u/l
0.39
30
181
16
64
2.55
2.90
1.4
1.3
—
—
—
0
0
16
64
2.55
2.90
1.4
1.3
—
—
—
0
0
47
286
1.71
2.84
1.9
2.0
230.15
220.59
pmol/l
0.25
47
273
97
701
1.47
2.83
2.9
2.9
2.43
2.43
mmol/l
0.32
84
628
11
34
3.28
2.74
1.0
1.1
—
—
—
0
0
163
1299
1.37
2.73
3.2
3.5
2.36
2.35
mmol/l
0.35
148
1201
472
4447
1.59
2.71
16.5
16.0
3.94
3.98
mmol/l
2.90
463
4366
23
112
2.10
2.71
2.7
1.7
—
—
—
0
0
12
40
3.05
2.71
1.2
1.1
—
—
—
0
0
202
1674
1.34
2.60
2.2
1.9
98.60
95.61
pmol/l
0.37
122
908
42
256
1.70
2.54
1.0
1.0
—
—
—
0
0
470
4437
1.55
2.52
16.4
15.9
139.39
139.68
mmol/l
2.05
465
4367
448
4193
1.46
2.46
6.9
5.6
37.83
38.76
mmol/mol
0.45
437
4017
29
160
1.86
2.44
1.3
1.6
0.03
0.06
iu/ml
—
10
26
14
59
2.41
2.31
1.4
1.4
196.17
165.48
pmol/l
0.73
14
59
17
80
2.16
2.21
1.1
1.0
2.20
1.79
eliau/ml
—
7
36
213
1814
1.29
2.16
2.5
2.5
75.57
73.38
nmol/l
0.50
194
1677
80
587
1.43
2.16
2.0
2.5
25.63
24.89
%
0.14
75
558
123
980
1.33
2.01
2.3
2.0
2.79
2.73
mg/l
0.10
107
857
22
119
1.89
2.00
1.3
1.4
—
—
—
0
0
357
3265
1.29
1.99
3.9
3.3
—
—
—
0
0
56
390
1.49
1.98
2.0
2.6
0.22
0.22
g/l
0.14
51
365
20
105
1.94
1.98
1.0
1.2
—
—
—
0
0
7
21
3.36
1.97
1.1
1.0
—
—
—
0
0
139
1131
1.31
1.96
2.5
2.6
351.00
358.14
umol/l
0.40
130
1030
105
823
1.34
1.92
1.9
2.1
1.54
1.48
%
0.30
91
748
25
144
1.77
1.88
2.2
2.9
—
—
—
0
0
43
287
1.54
1.86
1.7
1.6
—
—
—
0
0
11
46
2.42
1.86
1.2
1.2
—
—
—
0
0
111
1374
0.76
1.86
3.0
2.7
0.00
0.00
estimate
0.50
34
396
13
61
2.16
1.73
2.5
1.6
—
—
—
0
0
512
4991
1.91
1.71
26.7
20.7
252.42
247.74
e9/l
0.89
504
4923
83
642
1.35
1.66
2.0
2.5
2.29
2.31
g/l
0.10
78
598
14
69
2.06
1.66
1.5
1.2
—
—
—
0
0
7
25
2.82
1.65
1.6
3.4
909.57
736.84
u/ml
—
7
25
126
1039
1.28
1.59
3.3
3.3
1.02
1.02
kg/l
1.38
65
676
10
43
2.35
1.59
1.1
1.2
39.64
51.78
mg/l
—
10
31
512
4998
1.86
1.59
26.6
20.6
4.58
4.67
e12/l
3.89
499
4922
56
413
1.40
1.51
4.0
2.9
—
—
—
0
0
353
3282
1.23
1.43
3.7
3.8
14.70
14.64
pmol/l
0.16
330
3045
64
488
1.35
1.42
2.1
1.8
—
—
—
0
0
99
805
1.28
1.40
3.1
3.5
1314.97
691.69
ng/l
0.22
72
574
62
472
1.36
1.39
2.1
1.8
—
—
—
0
0
224
1996
1.21
1.38
2.8
2.7
—
—
estimate
—
0
0
9
42
2.16
1.34
1.1
1.1
271.67
253.18
mg/l
—
9
34
220
1963
1.21
1.33
6.1
7.9
1.20
1.21
mmol/l
0.15
192
1734
76
603
1.30
1.30
7.7
8.3
104.79
104.05
mmol/l
0.85
76
603
11
55
2.02
1.28
1.1
1.3
—
—
—
0
0
14
77
1.84
1.26
2.4
1.8
—
—
—
0
0
54
410
1.35
1.25
3.5
3.6
0.67
1.82
mmol/l
1.05
49
352
15
85
1.79
1.24
2.0
1.6
—
—
—
0
0
226
2043
1.19
1.14
2.9
2.9
132.57
139.17
ug/l
0.18
215
1948
8
41
1.97
1.09
1.1
1.1
—
—
—
0
0
7
33
2.14
1.06
1.9
2.7
—
—
—
0
0
80
659
1.25
1.04
2.0
1.9
—
—
—
0
0
5
22
2.28
1.03
2.6
2.5
0.30
1.09
%
—
5
22
5
22
2.28
1.03
1.4
1.2
—
—
—
0
0
5
109
0.45
1.01
1.8
1.6
—
—
—
0
0
9
49
1.85
0.99
1.6
1.2
—
—
—
0
0
5
23
2.18
0.98
1.0
1.2
49.20
19.18
u/l
—
5
17
5
23
2.18
0.98
1.2
1.1
656.08
157.89
iu/ml
—
5
23
7
36
1.96
0.97
1.6
1.1
—
—
—
0
0
7
36
1.96
0.97
1.6
1.1
—
—
—
0
0
19
125
1.54
0.95
1.0
1.2
315.85
259.03
u/ml
0.41
13
77
9
52
1.74
0.92
1.2
1.2
—
—
—
0
0
22
151
1.48
0.92
1.7
2.1
0.39
1.70
ug/l
1.29
17
133
8
42
1.92
0.89
3.4
4.1
—
—
—
0
0
61
497
1.26
0.89
8.2
10.7
0.33
0.91
mmol/l
0.63
53
423
13
79
1.66
0.88
1.2
1.0
0.16
0.38
u/ml
—
6
25
15
96
1.58
0.85
2.7
1.5
—
—
—
0
0
23
164
1.42
0.81
1.6
2.2
124.75
570.14
ug/l
1.00
23
158
29
217
1.36
0.78
1.7
1.6
—
—
—
0
0
13
82
1.60
0.78
1.2
1.3
—
—
—
0
0
0
27
0.00
0.77
0.0
1.1
—
104.86
—
0
22
6
34
1.77
0.76
1.5
1.5
16100.00
29490.41
e6/l
—
6
17
5
24
2.09
0.74
1.0
1.2
192.00
86.22
u/l
—
5
18
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
29
220
1.34
0.73
1.3
1.4
—
—
—
0
0
5
25
2.01
0.73
2.6
3.5
89.40
126.32
nmol/l
—
5
25
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
26
1.93
0.71
1.0
1.2
—
—
—
0
0
63
531
1.21
0.70
2.2
2.8
11.00
8.74
umol/l
0.27
53
473
469
4582
1.21
0.69
6.9
5.1
2.80
2.80
mmol/l
0.01
451
4354
123
1105
1.15
0.65
1.4
1.3
1.23
1.30
u/ml
0.06
33
327
414
4012
1.15
0.64
4.8
4.6
1.76
1.85
mu/l
0.99
396
3757
54
454
1.21
0.63
1.7
1.5
—
—
—
0
0
24
182
1.33
0.62
2.6
2.6
262.90
4311.79
u/l
—
6
71
153
1400
1.13
0.61
2.9
2.9
61.01
64.21
u/l
0.18
141
1318
5
30
1.67
0.61
1.2
1.2
—
—
—
0
0
13
88
1.49
0.61
2.6
1.5
—
—
—
0
0
8
51
1.58
0.60
1.6
1.4
—
—
—
0
0
145
1324
1.13
0.60
3.7
4.3
13.46
10.12
mg/mmol
0.21
90
886
0
21
0.00
0.60
0.0
4.5
—
64.37
—
0
21
113
1017
1.14
0.59
1.8
1.7
1.13
1.16
mg/l
0.05
86
760
0
23
0.00
0.58
0.0
1.0
—
0.47
—
0
23
13
89
1.47
0.58
1.8
1.5
—
—
—
0
0
6
36
1.67
0.57
1.8
1.2
111.00
108.11
pmol/l
—
6
36
464
4544
1.18
0.56
6.3
4.7
4.61
4.65
mmol/l
0.40
446
4329
9
60
1.51
0.54
2.9
1.5
—
—
—
0
0
6
38
1.59
0.54
1.5
1.2
35.17
51.05
u/l
—
6
32
6
40
1.51
0.51
1.3
1.2
—
—
—
0
0
14
190
0.73
0.50
3.8
3.3
25.14
24.91
mmol/l
0.13
14
181
6
41
1.47
0.50
1.3
1.1
—
—
—
0
0
16
119
1.36
0.48
2.2
1.7
—
—
—
0
0
7
46
1.53
0.48
1.3
1.1
—
—
—
0
0
13
94
1.39
0.46
2.8
3.6
—
3535.88
—
0
8
16
121
1.33
0.44
1.3
1.1
3.04
2.39
u/ml
—
9
68
29
240
1.22
0.42
2.6
2.5
0.66
0.66
%
0.02
29
240
361
3506
1.09
0.41
3.3
3.4
46.22
48.23
u/l
0.21
343
3371
5
33
1.52
0.41
2.2
1.5
—
—
—
0
0
5
33
1.52
0.41
1.8
1.5
—
11.00
—
0
6
0
15
0.00
0.41
0.0
1.7
—
43.25
—
0
15
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
15
0.00
0.41
0.0
1.1
—
111.13
—
0
15
0
15
0.00
0.41
0.0
1.0
—
90.22
—
0
9
440
4315
1.12
0.41
5.2
4.0
1.38
1.36
mmol/l
0.29
412
4079
0
16
0.00
0.41
0.0
1.1
—
108.60
—
0
10
23
186
1.25
0.41
1.5
1.9
1.83
5.08
iu/ml
—
6
40
12
88
1.37
0.40
1.2
1.1
—
1.87
—
0
6
0
18
0.00
0.40
0.0
2.6
—
—
—
0
0
0
18
0.00
0.40
0.0
2.6
—
—
—
0
0
79
716
1.12
0.39
1.3
1.3
10.07
7.14
u/ml
0.14
43
300
20
160
1.26
0.39
1.2
1.2
—
—
—
0
0
11
80
1.38
0.38
1.5
1.6
0.25
0.34
nmol/l
—
5
59
83
756
1.12
0.38
1.5
1.7
434.82
28097107.12
pmol/l
0.77
72
662
5
37
1.35
0.37
1.4
3.4
1389.80
1621.38
mg
—
5
37
5
37
1.35
0.37
1.0
1.5
—
—
—
0
0
19
234
0.80
0.36
2.4
3.2
1.17
1.78
mmol/l
0.29
13
173
127
1186
1.09
0.36
2.6
2.6
0.59
0.70
ug/l
1.10
80
617
6
42
1.43
0.35
1.3
1.1
—
—
—
0
0
6
42
1.43
0.35
1.3
1.1
—
—
—
0
0
34
292
1.18
0.35
1.2
1.3
34.19
110.50
u/ml
—
9
118
14
109
1.29
0.33
2.6
1.5
—
—
—
0
0
20
239
0.83
0.30
1.3
1.8
—
—
—
0
0
12
151
0.79
0.28
4.5
2.3
25.27
24.92
mmol/l
0.12
12
151
8
63
1.27
0.28
1.3
1.1
—
—
—
0
0
24
279
0.85
0.27
1.3
1.1
0.71
0.67
ratio
—
6
29
15
122
1.24
0.27
1.0
1.4
—
—
—
0
0
9
76
1.19
0.24
1.6
1.6
—
—
—
0
0
6
83
0.72
0.24
1.0
1.1
—
—
—
0
0
131
1249
1.06
0.23
3.8
3.4
0.00
0.01
estimate
0.69
37
455
12
97
1.24
0.23
2.4
2.2
143.29
134.93
g/l
—
7
72
158
1644
0.94
0.22
3.4
3.4
21.07
33.69
ng/l
1.89
93
1053
0
11
0.00
0.21
0.0
6.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
0.45
—
0
6
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
1.19
—
0
10
0
14
0.00
0.20
0.0
4.1
—
4.76
—
0
14
0
14
0.00
0.20
0.0
4.1
—
10.09
—
0
14
30
331
0.90
0.18
1.9
2.2
7.00
9.18
ug/l
0.58
25
301
11
91
1.21
0.17
1.5
1.2
5.00
4.34
u/ml
—
6
47
148
1531
0.95
0.17
3.2
3.6
22.94
21.48
%
0.39
53
574
7
63
1.11
0.17
1.4
1.4
—
—
—
0
0
11
92
1.20
0.16
1.5
1.6
—
—
—
0
0
457
4533
1.06
0.15
6.3
4.6
1.32
1.37
mmol/l
1.73
436
4299
9
80
1.13
0.15
1.1
1.2
16.69
16.26
u/l
—
9
72
67
705
0.94
0.14
2.3
2.0
4.08
3.69
ratio
0.77
55
554
110
1060
1.05
0.14
2.9
3.2
931.36
931.04
ng/l
0.00
94
885
16
141
1.14
0.14
1.2
2.4
10.49
11.85
mg/l
0.49
16
134
36
336
1.08
0.12
2.9
2.4
0.67
0.18
e6/l
0.94
30
323
12
104
1.16
0.12
3.0
2.0
8.78
8.37
kpa
0.54
12
104
14
124
1.13
0.11
2.3
1.7
—
—
—
0
0
82
792
1.04
0.10
1.5
1.3
37.53
25.90
iu/ml
0.41
22
223
5
44
1.14
0.10
1.0
1.2
—
—
—
0
0
5
48
1.04
0.09
1.0
1.4
—
—
—
0
0
197
1938
1.03
0.09
4.6
4.1
2.82
1.76
ug/l
0.66
184
1784
6
54
1.11
0.09
2.3
3.2
1.32
2.83
nmol/l
—
6
54
11
98
1.13
0.07
2.0
1.3
—
—
—
0
0
13
143
0.91
0.07
1.5
1.7
—
—
—
0
0
16
147
1.09
0.07
1.5
2.0
—
—
—
0
0
20
214
0.93
0.07
3.6
3.5
47.56
50.85
%
0.22
20
209
30
315
0.95
0.06
1.9
1.4
—
—
—
0
0
27
284
0.95
0.06
3.2
3.2
5.07
5.15
kpa
0.21
27
277
10
90
1.11
0.05
2.3
1.8
—
—
—
0
0
51
525
0.97
0.05
1.9
1.7
3.42
3.52
mmol/l
0.26
38
370
27
282
0.96
0.04
2.6
3.1
120.67
133.42
g/l
1.37
27
272
12
111
1.08
0.04
1.1
2.6
0.99
1.72
ratio
—
7
60
44
450
0.98
0.02
4.3
4.3
29.84
29.94
%
0.02
31
324
56
550
1.02
0.02
1.6
1.6
1139.91
1204.12
nmol/l
0.23
43
432
25
258
0.97
0.02
11.4
13.2
16.32
16.26
%
0.03
25
247
44
433
1.02
0.01
10.1
11.6
124.80
125.14
g/l
0.04
44
422
10
94
1.07
0.01
1.0
1.1
—
88.78
—
0
22
19
184
1.03
0.00
1.4
1.2
0.52
1.92
u/ml
—
5
15
42
426
0.98
0.00
5.0
6.7
—
—
—
0
0
10
96
1.04
0.00
1.7
1.4
—
—
—
0
0
11
114
0.96
0.00
1.5
1.6
—
—
—
0
0
187
1868
1.00
0.00
11.9
11.3
1.22
1.18
inr
0.42
144
1547
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
5
49
1.02
0.00
1.0
1.4
—
—
—
0
0
5
49
1.02
0.00
1.0
1.4
—
—
—
0
0
5
55
0.91
-0.00
1.4
1.1
—
—
—
0
0
5
57
0.88
-0.00
1.2
1.2
1.33
1.57
nmol/l
—
5
52
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
5.98
—
0
6
9
97
0.93
-0.00
1.3
1.2
—
—
—
0
0
7
78
0.90
-0.00
1.6
2.9
6.00
7.98
pmol/l
—
7
78
0
9
0.00
-0.00
0.0
1.9
—
1.27
—
0
9
5
52
0.96
-0.00
1.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
36.33
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
10.5
—
10.88
—
0
8
0
6
0.00
-0.00
0.0
2.7
—
0.50
—
0
6
7
70
1.00
-0.00
1.0
1.1
—
—
—
0
0
5
52
0.96
-0.00
1.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
-0.00
1.0
1.4
—
—
—
0
0
182
1820
1.00
-0.00
3.3
3.1
0.00
0.01
estimate
0.74
34
412
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: AB1_EARLY_SYPHILIS_WIDE – Early syphilis, including avohilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).